Estrogen receptor phosphorylation

Steroids

Volumn 68, Issue 1, 2003, Pages 1-9

  Lannigan, Deborah A ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Estrogen receptor; Phosphorylation; Transcription

Indexed keywords

AMINO ACID; CYCLIC AMP DEPENDENT PROTEIN KINASE; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; META TYROSINE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; SERINE; ESTROGEN RECEPTOR;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; DNA BINDING; ENZYME ACTIVATION; IN VIVO STUDY; LIGAND BINDING; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; HUMAN; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY;

CYCLIC AMP-DEPENDENT PROTEIN KINASES; ESTROGEN RECEPTOR ALPHA; HUMANS; MAP KINASE SIGNALING SYSTEM; PHOSPHORYLATION; RECEPTOR CROSS-TALK; RECEPTORS, ESTROGEN;

EID: 0037211754     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-128X(02)00110-1     Document Type: Review

References (124)

1. Mangelsdorf D.J., Thummel C., Beato M., Herrlich P., Schütz G., Umesono K.et al. The nuclear receptor superfamily: the second decade. Cell. 83:1995;835-839.
2. Power R.F., Mani S.K., Codina J., Conneely O.M., O'Malley B.W. Dopaminergic and ligand-independent activation of steroid hormone receptors. Science. 254:1991;1636-1639.
3. Ignar-Trowbridge D.M., Nelson K.G., Bidwell M.C., Curtis S.W., Washburn T.F., McLachlan J.A.et al. Coupling of dual signaling pathways: epidermal growth factor action involves the estrogen receptor. Proc. Natl. Acad. Sci. U.S.A. 89:1992;4658-4662.
4. Aronica S.M., Katzenellenbogen B.S. Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-1. Mol. Endocrinol. 7:1993;743-752.
5. Cho H., Katzenellenbogen B.S. Synergistic activation of estrogen receptor-mediated transcription by estradiol and protein kinase activators. Mol. Endocrinol. 7:1993;441-452.
6. Smith C.L., Conneely O.M., O'Malley B.W. Modulation of the ligand-independent activation of the human estrogen receptor by hormone and antihormone. Proc. Natl. Acad. Sci. U.S.A. 90:1993;6120-6124.
7. Ignar-Trowbridge D.M., Teng C.T., Ross K.A., Parker M.G., Korach K.S., McLachlan J.A. Peptide growth factors elicit estrogen receptor-dependent transcriptional activation of an estrogen-responsive element. Mol. Endocrinol. 7:1993;992-998.
8. Ince B.A., Montano M.M., Katzenellenbogen B.S. Activation of transcriptionally inactive human estrogen receptors by cyclic adenosine 3′,5′-monophosphate and ligands including antiestrogens. Mol. Endocrinol. 8:1994;1397-1406.
9. Le Goff P., Montano M.M., Schodin D.J., Katzenellenbogen B.S. Phosphorylation of the human estrogen receptor. Identification of hormone-regulated sites and examination of their influence on transcriptional activity. J. Biol. Chem. 269:1994;4458-4466.
10. Aronica S.M., Kraus W.L., Katzenellenbogen B.S. Estrogen action via the cAMP signaling pathway: stimulation of adenylate cyclase and cAMP-regulated gene transcription. Proc. Natl. Acad. Sci. U.S.A. 91:1994;8517-8521.
11. Ignar-Trowbridge D.M., Pimentel M., Parker M.G., McLachlan J.A., Korach K.S. Peptide growth factor cross-talk with the estrogen receptor requires the A/B domain and occurs independently of protein kinase C or estradiol. Endocrinology. 137:1996;1735-1744.
12. Bunone G., Briand P.A., Miksicek R.J., Picard D. Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J. 15:1996;2174-2183.
13. Curtis S.W., Washburn T., Sewall C., DiAugustine R., Lindzey J., Couse J.F.et al. Physiological coupling of growth factor and steroid receptor signaling pathways: estrogen receptor knockout mice lack estrogen-like response to epidermal growth factor. Proc. Natl. Acad. Sci. U.S.A. 93:1996;12626-12630.
14. Joel P.B., Traish A.M., Lannigan D.A. Estradiol-induced phosphorylation of Serine 118 in the estrogen receptor is independent of p42/p44 mitogen-activated protein kinase. J. Biol. Chem. 273:1998;13317-13323.
15. Klotz D.M., Hewitt S.C., Ciana P., Raviscioni M., Lindzey J.K., Foley J.et al. Requirement of estrogen receptor-alpha in insulin-like growth factor-1 (IGF-1)-induced uterine responses and in vivo evidence for IGF-1/estrogen receptor cross-talk. J. Biol. Chem. 277:2002;8531-8537.
16. Schreihofer D.A., Resnick E.M., Lin V.Y., Shupnik M.A. Ligand-independent activation of pituitary ER: dependence on PKA-stimulated pathways. Endocrinology. 142:2001;3361-3368.
17. Gustafsson J.A. An update on estrogen receptors. Semin. Perinatol. 24:2000;66-69.
18. Kuiper G.G., Lemmen J.G., Carlsson B., Corton J.C., Safe S.H., van der Saag P.T.et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology. 139:1998;4252-4263.
19. Katzenellenbogen B.S., Montano M.M., Ediger T.R., Sun J., Ekena K., Lazennec G.et al. Estrogen receptors: selective ligands, partners, and distinctive pharmacology. Recent Prog. Horm. Res. 55:2000;163-193.
20. Hopp T.A., Fuqua S.A. Estrogen receptor variants. J. Mammary Gland Biol. Neoplasia. 3:1998;73-83.
21. Shupnik M.A., Pitt L.K., Soh A.Y., Anderson A., Lopes M.B., Laws E.R. Selective expression of estrogen receptor alpha and beta isoforms in human pituitary tumors. J. Clin. Endocrinol. Metab. 83:1998;3965-3972.
22. Jazaeri O., Shupnik M.A., Jazaeri A.A., Rice L.W. Expression of estrogen receptor alpha mRNA and protein variants in human endometrial carcinoma. Gynecol. Oncol. 74:1999;38-47.
23. Schreihofer D.A., Stoler M.H., Shupnik M.A. Differential expression and regulation of estrogen receptors (ERs) in rat pituitary and cell lines: estrogen decreases ERalpha protein and estrogen responsiveness. Endocrinology. 141:2000;2174-2184.
24. Kumar R., Thompson E.B. The structure of the nuclear hormone receptors. Steroids. 64:1999;310-319.
25. Lees J.A., Fawell S.E., Parker M.G. Identification of two transactivation domains in the mouse oestrogen receptor. Nucleic Acids Res. 17:1989;5477-5488.
26. Crowe D.L., Brown T.N., Kim R., Smith S.M., Lee M.K. A c-fos/estrogen receptor fusion protein promotes cell cycle progression and proliferation of human cancer cell lines. Mol. Cell. Biol. Res. Commun. 3:2000;243-248.
27. Kametaka M., Kume A., Mizukami H., Hanazono Y., Ozawa K. A suicide gene encoding fas-estrogen receptor chimeric molecule for inducible apoptosis of cytotoxic T lymphocytes. Exp. Hematol. 28:2000;1495.
28. Fialka I., Schwarz H., Reichmann E., Oft M., Busslinger M., Beug H. The estrogen-dependent c-JunER protein causes a reversible loss of mammary epithelial cell polarity involving a destabilization of adherens junctions. J. Cell Biol. 132:1996;1115-1132.
29. Littlewood T.D., Hancock D.C., Danielian P.S., Parker M.G., Evan G.I. A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res. 23:1995;1686-1690.
30. Boehmelt G., Madruga J., Dorfler P., Briegel K., Schwarz H., Enrietto P.J.et al. Dendritic cell progenitor is transformed by a conditional v-Rel estrogen receptor fusion protein v-RelER. Cell. 80:1995;341-352.
31. Kraus W.L., McInerney E.M., Katzenellenbogen B.S. Ligand-dependent, transcriptionally productive association of the amino-and carboxyl-terminal regions of a steroid hormone nuclear receptor. Proc. Natl. Acad. Sci. U.S.A. 92:1995;12314-12318.
32. Gandini O., Kohno H., Curtis S., Korach K.S. Two transcription activation functions in the amino terminus of the mouse estrogen receptor that are affected by the carboxy terminus. Steroids. 62:1997;508-515.
33. Tora L., White J., Brou C., Tasset D., Webster N., Scheer E.et al. The human estrogen receptor has two independent nonacidic transcriptional activation functions. Cell. 59:1989;477-487.
34. Tzukerman M.T., Esty A., Santiso-Mere D., Danielian P., Parker M.G., Stein R.B.et al. Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. Mol. Endocrinol. 8:1994;21-30.
35. Webster N.J., Green S., Jin J.R., Chambon P. The hormone-binding domains of the estrogen and glucocorticoid receptors contain an inducible transcription activation function. Cell. 54:1988;199-207.
36. Feng W., Ribeiro R.C., Wagner R.L., Nguyen H., Apriletti J.W., Fletterick R.J.et al. Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors. Science. 280:1998;1747-1749.
37. Darimont B.D., Wagner R.L., Apriletti J.W., Stallcup M.R., Kushner P.J., Baxter J.D.et al. Structure and specificity of nuclear receptor-coactivator interactions. Genes Dev. 12:1998;3343-3356.
38. Shiau A.K., Barstad D., Loria P.M., Cheng L., Kushner P.J., Agard D.A.et al. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell. 95:1998;927-937.
39. Mak H.Y., Hoare S., Henttu P.M., Parker M.G. Molecular determinants of the estrogen receptor-coactivator interface. Mol. Cell. Biol. 19:1999;3895-3903.
40. Nichols M., Rientjes J.M., Stewart A.F. Different positioning of the ligand-binding domain helix 12 and the F domain of the estrogen receptor accounts for functional differences between agonists and antagonists. EMBO J. 17:1998;765-773.
41. Brzozowski A.M., Pike A.C., Dauter Z., Hubbard R.E., Bonn T., Engstrom O.et al. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature. 389:1997;753-758.
42. Denton R.R., Koszewski N.J., Notides A.C. Estrogen receptor phosphorylation: hormonal dependence and consequence on specific DNA binding. J. Biol. Chem. 267:1992;7263-7268.
43. Washburn T., Hocutt A., Brautigan D.L., Korach K.S. Uterine estrogen receptor in vivo: phosphorylation of nuclear specific forms on serine residues. Mol. Endocrinol. 5:1991;235-242.
44. Joel P.B., Traish A.M., Lannigan D.A. Estradiol and phorbol ester cause phosphorylation of serine 118 in the human estrogen receptor. Mol. Endocrinol. 9:1995;1041-1052.
45. Tremblay G.B., Tremblay A., Copeland N.G., Gilbert D.J., Jenkins N.A., Labrie F.et al. Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor beta. Mol. Endocrinol. 11:1997;353-365.
46. Ali S., Metzger D., Bornert J.M., Chambon P. Modulation of transcriptional activation by ligand-dependent phosphorylation of the human oestrogen receptor A/B region. EMBO J. 12:1993;1153-1160.
47. Lahooti H., White R., Danielian P.S., Parker M.G. Characterization of ligand-dependent phosphorylation of the estrogen receptor. Mol. Endocrinol. 8:1994;182-188.
48. Lahooti H., White R., Hoare S.A., Rahman D., Pappin D.J., Parker M.G. Identification of phosphorylation sites in the mouse oestrogen receptor. J. Steroid Biochem. Mol. Biol. 55:1995;305-313.
49. Arnold S.F., Melamed M., Vorojeikina D.P., Notides A.C., Sasson S. Estradiol-binding mechanism and binding capacity of the human estrogen receptor is regulated by tyrosine phosphorylation. Mol. Endocrinol. 11:1997;48-53.
50. Arnold S.F., Obourn J.D., Jaffe H., Notides A.C. Phosphorylation of the human estrogen receptor on tyrosine 537 in vivo and by Src family tyrosine kinases in vitro. Mol. Endocrinol. 9:1995;24-33.
51. Arnold S.F., Vorojeikina D.P., Notides A.C. Phosphorylation of tyrosine 537 on the human estrogen receptor is required for binding to an estrogen response element. J. Biol. Chem. 270:1995;30205-30212.
52. Auricchio F., Migliaccio A., Castoria G., Di Domenico M., Pagano M. Phosphorylation of uterus estradiol receptor on tyrosine. Prog. Clin. Biol. Res. 322:1990;133-155.
53. Auricchio F., Migliaccio A., Castoria G., Rotondi A., Di Domenico M., Pagano M.et al. Phosphorylation of estradiol receptor on tyrosine and interaction of estradiol and glucocorticoid receptors with antiphosphotyrosine antibodies. Adv. Exp. Med. Biol. 231:1988;519-540.
54. Joel P.B., Smith J., Sturgill T.W., Fisher T.L., Blenis J., Lannigan D.A. pp90rsk1 regulates estrogen receptor-mediated transcription through phosphorylation of Ser-167. Mol. Cell. Biol. 18:1998;1978-1984.
55. Rogatsky I., Trowbridge J.M., Garabedian M.J. Potentiation of human estrogen receptor alpha transcriptional activation through phosphorylation of serines 104 and 106 by the cyclin A-CDK2 complex. J. Biol. Chem. 274:1999;22296-22302.
56. Kato S., Endoh H., Masuhiro Y., Kitamoto T., Uchiyama S., Sasaki H.et al. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science. 270:1995;1491-1494.
57. Migliaccio A., Di Domenico M., Castoria G., de Falco A., Bontempo P., Nola E.et al. Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J. 15:1996;1292-1300.
58. Migliaccio A., Piccolo D., Castoria G., Didomenico M., Bilancio A., Lombardi M.et al. Activation of the src/p21(Ras)/Erk pathway by progesterone receptor via cross-talk with estrogen receptor. EMBO J. 17:1998;2008-2018.
59. Migliaccio A., Castoria G., Di Domenico M., de Falco A., Bilancio A., Lombardi M.et al. Steroid-induced androgen receptor-oestradiol receptor beta-Src complex triggers prostate cancer cell proliferation. EMBO J. 19:2000;5406-5417.
60. Chen D., Riedl T., Washbrook E., Pace P.E., Coombes R.C., Egly J.M.et al. Activation of estrogen receptor alpha by S118 phosphorylation involves a ligand-dependent interaction with TFIIH and participation of CDK7. Mol. Cell. 6:2000;127-137.
61. Lobenhofer E.K., Marks J.R. Estrogen-induced mitogenesis of MCF-7 cells does not require the induction of mitogen-activated protein kinase activity. J. Steroid Biochem. Mol. Biol. 75:2000;11-20.
62. Lobenhofer E.K., Huper G., Iglehart J.D., Marks J.R. Inhibition of mitogen-activated protein kinase and phosphatidylinositol 3-kinase activity in MCF-7 cells prevents estrogen-induced mitogenesis. Cell Growth Differ. 11:2000;99-110.
63. Caristi S., Galera J.L., Matarese F., Imai M., Caporali S., Cancemi M.et al. Estrogens do not modify MAP kinase-dependent nuclear signaling during stimulation of early G(1) progression in human breast cancer cells. Cancer Res. 61:2001;6360-6366.
64. Watters J.J., Campbell J.S., Cunningham M.J., Krebs E.G., Dorsa D.M. Rapid membrane effects of steroids in neuroblastoma cells: effects of estrogen on mitogen activated protein kinase signalling cascade and c-fos immediate early gene transcription. Endocrinology. 138:1997;4030-4033.
65. Hisamoto K., Ohmichi M., Kurachi H., Hayakawa J., Kanda Y., Nishio Y.et al. Estrogen induces the Akt-dependent activation of endothelial nitric oxide synthase in vascular endothelial cells. J. Biol. Chem. 23:2000;23.
66. Manthey D., Heck S., Engert S., Behl C. Estrogen induces a rapid secretion of amyloid beta precursor protein via the mitogen-activated protein kinase pathway. Eur. J. Biochem. 268:2001;4285-4291.
67. Singh M., Setalo G. Jr., Guan X., Frail D.E., Toran-Allerand C.D. Estrogen-induced activation of the mitogen-activated protein kinase cascade in the cerebral cortex of estrogen receptor-alpha knock-out mice. J. Neurosci. 20:2000;1694-1700.
68. Arnold S.F., Obourn J.D., Jaffe H., Notides A.C. Serine 167 is the major estradiol-induced phosphorylation site on the human estrogen receptor. Mol. Endocrinol. 8:1994;1208-1214.
69. Clark D.E., Poteet-Smith C.E., Smith J.A., Lannigan D.A. Rsk2 allosterically activates estrogen receptor alpha by docking to the hormone-binding domain. EMBO J. 20:2001;3484-3494.
70. Frodin M., Gammeltoft S. Role and regulation of 90 kDa ribosomal S6 kinase (RSK) in signal transduction. Mol. Cell. Endocrinol. 151:1999;65-77.
71. Arnold S.F., Obourn J.D., Jaffe H., Notides A.C. Phosphorylation of the human estrogen receptor by mitogen-activated protein kinase and casein kinase. II. Consequence on DNA binding. J. Steroid Biochem. Mol. Biol. 55:1995;163-172.
72. Martin M.B., Franke T.F., Stoica G.E., Chambon P., Katzenellenbogen B.S., Stoica B.A.et al. A role for Akt in mediating the estrogenic functions of epidermal growth factor and insulin-like growth factor I. Endocrinology. 141:2000;4503-4511.
73. Campbell R.A., Bhat-Nakshatri P., Patel N.M., Constantinidou D., Ali S., Nakshatri H. PI3 kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance. J. Biol. Chem. 3:2001;3.
74. Sun M., Paciga J.E., Feldman R.I., Yuan Z., Coppola D., Lu Y.Y.et al. Phosphatidylinositol-3-OH kinase (PI3K)/AKT2, activated in breast cancer, regulates and is induced by estrogen receptor alpha (ERalpha) via interaction between ERalpha and PI3K. Cancer Res. 61:2001;5985-5991.
75. Davies S.P., Reddy H., Caivano M., Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351:2000;95-105.
76. Chen D., Pace P.E., Coombes R.C., Ali S. Phosphorylation of human estrogen receptor alpha by protein kinase A regulates dimerization. Mol. Cell. Biol. 19:1999;1002-1015.
77. Yudt M.R., Vorojeikina D., Zhong L., Skafar D.F., Sasson S., Gasiewicz T.A.et al. Function of estrogen receptor tyrosine 537 in hormone binding, DNA binding, and transactivation. Biochemistry. 38:1999;14146-14156.
78. Migliaccio A., Rotondi A., Auricchio F. Estradiol receptor: phosphorylation on tyrosine in uterus and interaction with anti-phosphotyrosine antibody. EMBO J. 5:1986;2867-2872.
79. Migliaccio A., Pagano M., Auricchio F. Immediate and transient stimulation of protein tyrosine phosphorylation by estradiol in MCF-7 cells. Oncogene. 8:1993;2183-2191.
80. Pietras R.J., Arboleda J., Reese D.M., Wongvipat N., Pegram M.D., Ramos L.et al. HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells. Oncogene. 10:1995;2435-2446.
81. Castoria G., Migliaccio A., Green S., Di Domenico M., Chambon P., Auricchio F. Properties of a purified estradiol-dependent calf uterus tyrosine kinase. Biochemistry. 32:1993;1740-1750.
82. Tremblay A., Tremblay G.B., Labrie F., Giguere V. Ligand-independent recruitment of SRC-1 to estrogen receptor beta through phosphorylation of activation function AF-1. Mol. Cell. 3:1999;513-519.
83. Endoh H., Maruyama K., Masuhiro Y., Kobayashi Y., Goto M., Tai H.et al. Purification and identification of p68 RNA helicase acting as a transcriptional coactivator specific for the activation function 1 of human estrogen receptor alpha. Mol. Cell. Biol. 19:1999;5363-5372.
84. Lavinsky R.M., Jepsen K., Heinzel T., Torchia J., Mullen T.M., Schiff R.et al. Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes. Proc. Natl. Acad. Sci. U.S.A. 95:1998;2920-2925.
85. Ali S., Metzger D., Bornert J.-M., Chambon P. Modulation of transcriptional activation by ligand-dependent phosphorylation of the human oestrogen receptor A/B region. EMBO J. 12:1993;1153-1160.
86. Rowan B.G., Weigel N.L., O'Malley B.W. Phosphorylation of steroid receptor coactivator-1. Identification of the phosphorylation sites and phosphorylation through the mitogen-activated protein kinase pathway. J. Biol. Chem. 275:2000;4475-4483.
87. Font de Mora J., Brown M. AIB1 is a conduit for kinase-mediated growth factor signaling to the estrogen receptor. Mol. Cell. Biol. 20:2000;5041-5047.
88. Webb P., Nguyen P., Shinsako J., Anderson C., Feng W., Nguyen M.P.et al. Estrogen receptor activation function 1 works by binding p160 coactivator proteins. Mol. Endocrinol. 12:1998;1605-1618.
89. Lopez G.N., Turck C.W., Schaufele F., Stallcup M.R., Kushner P.J. Growth factors signal to steroid receptors through mitogen-activated protein kinase regulation of p160 coactivator activity. J. Biol. Chem. 276:2001;22177-22182.
90. El-Tanani M.K., Green C.D. Two separate mechanisms for ligand-independent activation of the estrogen receptor. Mol. Endocrinol. 11:1997;928-937.
91. Lazennec G., Thomas J.A., Katzenellenbogen B.S. Involvement of cyclic AMP response element binding protein (CREB) and estrogen receptor phosphorylation in the synergistic activation of the estrogen receptor by estradiol and protein kinase activators. J. Steroid Biochem. Mol. Biol. 77:2001;193-203.
92. Lamb J., Ladha M.H., McMahon C., Sutherland R.L., Ewen M.E. Regulation of the functional interaction between cyclin D1 and the estrogen receptor. Mol. Cell. Biol. 20:2000;8667-8675.
93. Zwijsen R.M., Wientjens E., Klompmaker R., van der Sman J., Bernards R., Michalides R.J. CDK-independent activation of estrogen receptor by cyclin D1. Cell. 88:1997;405-415.
94. Neuman E., Ladha M.H., Lin N., Upton T.M., Miller S.J., DiRenzo J.et al. Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4. Mol. Cell. Biol. 17:1997;5338-5347.
95. Weis K.E., Ekena K., Thomas J.A., Lazennec G., Katzenellenbogen B.S. Constitutively active human estrogen receptors containing amino acid substitutions for tyrosine 537 in the receptor protein. Mol. Endocrinol. 10:1996;1388-1398.
96. White R., Sjoberg M., Kalkhoven E., Parker M.G. Ligand-independent activation of the oestrogen receptor by mutation of a conserved tyrosine. EMBO J. 16:1997;1427-1435.
97. Ma Z.Q., Liu Z., Ngan E.S., Tsai S.Y. Cdc25B functions as a novel coactivator for the steroid receptors. Mol. Cell. Biol. 21:2001;8056-8067.
98. Dean D.A., Urban G., Aragon I.V., Swingle M., Miller B., Rusconi S.et al. Serine/threonine protein phosphatase 5 (PP5) participates in the regulation of glucocorticoid receptor nucleocytoplasmic shuttling. BMC Cell Biol. 2:2001;6.
99. Auricchio F., Di Domenico M., Migliaccio A., Castoria G., Bilancio A. The role of estradiol receptor in the proliferative activity of vanadate on MCF-7 cells. Cell Growth Differ. 6:1995;105-113.
100. Griswold-Prenner I., Carlin C.R., Rosner M.R. Mitogen-activated protein kinase regulates the epidermal growth factor receptor through activation of a tyrosine phosphatase. J. Biol. Chem. 268:1993;13050-13054.
101. Kahlert S., Nuedling S., van Eickels M., Vetter H., Meyer R., Grohe C. Estrogen receptor alpha rapidly activates the IGF-1 receptor pathway. J. Biol. Chem. 275:2000;18447-18453.
102. Watters J.J., Chun T.Y., Kim Y.N., Bertics P.J., Gorski J. Estrogen modulation of prolactin gene expression requires an intact mitogen-activated protein kinase signal transduction pathway in cultured rat pituitary cells. Mol. Endocrinol. 14:2000;1872-1881.
103. Filardo E.J., Quinn J.A., Bland K.I., Frackelton A.R. Jr. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF [In Process Citation]. Mol. Endocrinol. 14:2000;1649-1660.
104. Filardo E.J., Quinn J.A., Frackelton A.R. Jr., Bland K.I. Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis. Mol. Endocrinol. 16:2002;70-84.
105. Boonyaratanakornkit V., Scott M.P., Ribon V., Sherman L., Anderson S.M., Maller J.L.et al. Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases. Mol. Cell. 8:2001;269-280.
106. Improta-Brears T., Whorton A.R., Codazzi F., York J.D., Meyer T., McDonnell D.P. Estrogen-induced activation of mitogen-activated protein kinase requires mobilization of intracellular calcium. Proc. Natl. Acad. Sci. U.S.A. 96:1999;4686-4691.
107. Song R.X., McPherson R.A., Adam L., Bao Y., Shupnik M., Kumar R.et al. Linkage of rapid estrogen action to MAPK activation by ERalpha-Shc association and Shc pathway activation. Mol. Endocrinol. 16:2002;116-127.
108. Duan R., Xie W., Safe S. Estrogen receptor-mediated activation of the serum response element in MCF-7 cells through MAPK-dependent phosphorylation of Elk-1. J. Biol. Chem. 5:2001;5.
109. Marshall C.J. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell. 80:1995;179-185.
110. Cowley S., Paterson H., Kemp P., Marshall C.J. Activation of MAP kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell. 77:1994;841-852.
111. York R.D., Yao H., Dillon T., Ellig C.L., Eckert S.P., McCleskey E.W.et al. Rap1 mediates sustained MAP kinase activation induced by nerve growth factor. Nature. 392:1998;622-626.
112. Sabbagh W. Jr., Flatauer L.J., Bardwell A.J., Bardwell L. Specificity of MAP kinase signaling in yeast differentiation involves transient versus sustained MAPK activation. Mol. Cell. 8:2001;683-691.
113. Simoncini T., Hafezi-Moghadam A., Brazil D.P., Ley K., Chin W.W., Liao J.K. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature. 407:2000;538-541.
114. Haynes M.P., Sinha D., Russell K.S., Collinge M., Fulton D., Morales-Ruiz M.et al. Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells. Circ. Res. 87:2000;677-682.
115. Castoria G., Migliaccio A., Bilancio A., Di Domenico M., de Falco A., Lombardi M.et al. PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells. EMBO J. 20:2001;6050-6059.
116. Katso R., Okkenhaug K., Ahmadi K., White S., Timms J., Waterfield M.D. Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis, and cancer. Annu. Rev. Cell Dev. Biol. 17:2001;615-675.
117. Tsai E.M., Wang S.C., Lee J.N., Hung M.C. Akt activation by estrogen in estrogen receptor-negative breast cancer cells. Cancer Res. 61:2001;8390-8392.
118. Slentz-Kesler K., Moore J.T., Lombard M., Zhang J., Hollingsworth R., Weiner M.P. Identification of the human mnk2 gene (MKNK2) through protein interaction with estrogen receptor beta. Genomics. 69:2000;63-71.
119. Bodwell J.E., Webster J.C., Jewell C.M., Cidlowski J.A., Hu J.M., Munck A. Glucocorticoid receptor phosphorylation: overview, function and cell cycle-dependence. J. Steroid Biochem. Mol. Biol. 65:1998;91-99.
120. Lange C.A., Shen T., Horwitz K.B. Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome. Proc. Natl. Acad. Sci. U.S.A. 97:2000;1032-1037.
121. Webster J.C., Jewell C.M., Bodwell J.E., Munck A., Sar M., Cidlowski J.A. Mouse glucocorticoid receptor phosphorylation status influences multiple functions of the receptor protein. J. Biol. Chem. 272:1997;9287-9293.
122. Nawaz Z., Lonard D.M., Dennis A.P., Smith C.L., O'Malley B.W. Proteasome-dependent degradation of the human estrogen receptor. Proc. Natl. Acad. Sci. U.S.A. 96:1999;1858-1862.
123. Alarid E.T., Bakopoulos N., Solodin N. Proteasome-mediated proteolysis of estrogen receptor: a novel component in autologous down-regulation. Mol. Endocrinol. 13:1999;1522-1534.
124. Lonard D.M., Nawaz Z., Smith C.L., O'Malley B.W. The 26S proteasome is required for estrogen receptor-alpha and coactivator turnover and for efficient estrogen receptor-alpha transactivation. Mol. Cell. 5:2000;939-948.